Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

07.08.2019 | case report | Ausgabe 3/2019 Open Access

memo - Magazine of European Medical Oncology 3/2019

A wearable cardioverter defibrillator for prevention of sudden cardiac death in a hematologic patient—a case report

memo - Magazine of European Medical Oncology > Ausgabe 3/2019
Stefan Hatzl, Hildegard T. Greinix, Philipp Kreuzer, Eduard Schulz, Peter Neumeister, Daniel Scherr
Wichtige Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


The wearable cardioverter defibrillator (WCD) is a suitable option to overcome life-threatening episodes of malignant arrhythmia. There is much experience in the use of these devices in patients with idiopathic arrhythmia as well as in patients at a high risk for sudden cardiac death. However, there is lack of experience with WCD usage in hematologic patients with a limited expected lifespan. Here, we report a rare case of malignant arrhythmia in a patient with cardiac relapse of diffuse large B‑cell lymphoma (DLBCL) and the option of WCD use. WCD provides the possibility of bridging to implantation of a cardioverter defibrillator (ICD) in cases with a high risk of hemorrhage as well as being a definite therapy in patients with limited life expectance.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 3/2019

memo - Magazine of European Medical Oncology 3/2019 Zur Ausgabe